A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.
Identifieur interne : 001428 ( Main/Corpus ); précédent : 001427; suivant : 001429A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.
Auteurs : Rebecca Cosgriff ; Susannah Ahern ; Scott C. Bell ; Keith Brownlee ; Pierre-Régis Burgel ; Cass Byrnes ; Harriet Corvol ; Stephanie Y. Cheng ; Alexander Elbert ; Albert Faro ; Christopher H. Goss ; Vincent Gulmans ; Bruce C. Marshall ; Edward Mckone ; Peter G. Middleton ; Rasa Ruseckaite ; Anne L. Stephenson ; Siobhán B. CarrSource :
- Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [ 1873-5010 ] ; 2020.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Australia (MeSH), Betacoronavirus (MeSH), Canada (MeSH), Coronavirus Infections (complications), Coronavirus Infections (diagnosis), Coronavirus Infections (therapy), Cystic Fibrosis (complications), Cystic Fibrosis (therapy), Cystic Fibrosis (virology), Europe (MeSH), Female (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), New Zealand (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (diagnosis), Pneumonia, Viral (therapy), Symptom Assessment (MeSH), United States (MeSH), Young Adult (MeSH).
- MESH :
- geographic : Australia, Canada, Europe, New Zealand, United States.
- complications : Coronavirus Infections, Cystic Fibrosis, Pneumonia, Viral.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- therapy : Coronavirus Infections, Cystic Fibrosis, Pneumonia, Viral.
- virology : Cystic Fibrosis.
- Adolescent, Adult, Betacoronavirus, Female, Humans, Male, Middle Aged, Pandemics, Symptom Assessment, Young Adult.
Abstract
Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2, on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in people with cystic fibrosis.
METHODS
Anonymised data submitted by each participating country to their National CF Registry was reported using a standardised template, then collated and summarised.
RESULTS
40 cases have been reported across 8 countries. Of the 40 cases, 31 (78%) were symptomatic for SARS-CoV-2 at presentation, with 24 (60%) having a fever. 70% have recovered, 30% remain unresolved at time of reporting, and no deaths have been submitted.
CONCLUSIONS
This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort. The disease course does not seem to differ from the general population, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection.
DOI: 10.1016/j.jcf.2020.04.012
PubMed: 32376098
PubMed Central: PMC7183287
Links to Exploration step
pubmed:32376098Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.</title><author><name sortKey="Cosgriff, Rebecca" sort="Cosgriff, Rebecca" uniqKey="Cosgriff R" first="Rebecca" last="Cosgriff">Rebecca Cosgriff</name><affiliation><nlm:affiliation>Cystic Fibrosis Trust, London, UK. Electronic address: rebecca.cosgriff@cysticfibrosis.org.uk.</nlm:affiliation></affiliation></author><author><name sortKey="Ahern, Susannah" sort="Ahern, Susannah" uniqKey="Ahern S" first="Susannah" last="Ahern">Susannah Ahern</name><affiliation><nlm:affiliation>Monash University, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Bell, Scott C" sort="Bell, Scott C" uniqKey="Bell S" first="Scott C" last="Bell">Scott C. Bell</name><affiliation><nlm:affiliation>The Prince Charles Hospital, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Brownlee, Keith" sort="Brownlee, Keith" uniqKey="Brownlee K" first="Keith" last="Brownlee">Keith Brownlee</name><affiliation><nlm:affiliation>Cystic Fibrosis Trust, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Burgel, Pierre Regis" sort="Burgel, Pierre Regis" uniqKey="Burgel P" first="Pierre-Régis" last="Burgel">Pierre-Régis Burgel</name><affiliation><nlm:affiliation>Université de Paris, Inserm U1016, Institut Cochin and Cochin Hospital, Assistance Publique Hôpitaux de Paris (APHP).</nlm:affiliation></affiliation></author><author><name sortKey="Byrnes, Cass" sort="Byrnes, Cass" uniqKey="Byrnes C" first="Cass" last="Byrnes">Cass Byrnes</name><affiliation><nlm:affiliation>University of Auckland, Auckland, New Zealand.</nlm:affiliation></affiliation></author><author><name sortKey="Corvol, Harriet" sort="Corvol, Harriet" uniqKey="Corvol H" first="Harriet" last="Corvol">Harriet Corvol</name><affiliation><nlm:affiliation>Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Cheng, Stephanie Y" sort="Cheng, Stephanie Y" uniqKey="Cheng S" first="Stephanie Y" last="Cheng">Stephanie Y. Cheng</name><affiliation><nlm:affiliation>Cystic Fibrosis Canada, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Elbert, Alexander" sort="Elbert, Alexander" uniqKey="Elbert A" first="Alexander" last="Elbert">Alexander Elbert</name><affiliation><nlm:affiliation>Cystic Fibrosis Foundation, Bethesda, US.</nlm:affiliation></affiliation></author><author><name sortKey="Faro, Albert" sort="Faro, Albert" uniqKey="Faro A" first="Albert" last="Faro">Albert Faro</name><affiliation><nlm:affiliation>Cystic Fibrosis Foundation, Bethesda, US.</nlm:affiliation></affiliation></author><author><name sortKey="Goss, Christopher H" sort="Goss, Christopher H" uniqKey="Goss C" first="Christopher H" last="Goss">Christopher H. Goss</name><affiliation><nlm:affiliation>University of Washington, Seattle, US.</nlm:affiliation></affiliation></author><author><name sortKey="Gulmans, Vincent" sort="Gulmans, Vincent" uniqKey="Gulmans V" first="Vincent" last="Gulmans">Vincent Gulmans</name><affiliation><nlm:affiliation>Dutch CF Foundation NCFS, Baarn, Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Marshall, Bruce C" sort="Marshall, Bruce C" uniqKey="Marshall B" first="Bruce C" last="Marshall">Bruce C. Marshall</name><affiliation><nlm:affiliation>Cystic Fibrosis Foundation, Bethesda, US.</nlm:affiliation></affiliation></author><author><name sortKey="Mckone, Edward" sort="Mckone, Edward" uniqKey="Mckone E" first="Edward" last="Mckone">Edward Mckone</name><affiliation><nlm:affiliation>St Vincent's University Hospital, Dublin, Ireland.</nlm:affiliation></affiliation></author><author><name sortKey="Middleton, Peter G" sort="Middleton, Peter G" uniqKey="Middleton P" first="Peter G" last="Middleton">Peter G. Middleton</name><affiliation><nlm:affiliation>Westmead Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Ruseckaite, Rasa" sort="Ruseckaite, Rasa" uniqKey="Ruseckaite R" first="Rasa" last="Ruseckaite">Rasa Ruseckaite</name><affiliation><nlm:affiliation>Monash University, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Stephenson, Anne L" sort="Stephenson, Anne L" uniqKey="Stephenson A" first="Anne L" last="Stephenson">Anne L. Stephenson</name><affiliation><nlm:affiliation>Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Paris, France; Toronto Adult Cystic Fibrosis Centre, St. Michael's Hospital, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Carr, Siobhan B" sort="Carr, Siobhan B" uniqKey="Carr S" first="Siobhán B" last="Carr">Siobhán B. Carr</name><affiliation><nlm:affiliation>Royal Brompton Hospital and Imperial College London, UK.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32376098</idno><idno type="pmid">32376098</idno><idno type="doi">10.1016/j.jcf.2020.04.012</idno><idno type="pmc">PMC7183287</idno><idno type="wicri:Area/Main/Corpus">001428</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001428</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.</title><author><name sortKey="Cosgriff, Rebecca" sort="Cosgriff, Rebecca" uniqKey="Cosgriff R" first="Rebecca" last="Cosgriff">Rebecca Cosgriff</name><affiliation><nlm:affiliation>Cystic Fibrosis Trust, London, UK. Electronic address: rebecca.cosgriff@cysticfibrosis.org.uk.</nlm:affiliation></affiliation></author><author><name sortKey="Ahern, Susannah" sort="Ahern, Susannah" uniqKey="Ahern S" first="Susannah" last="Ahern">Susannah Ahern</name><affiliation><nlm:affiliation>Monash University, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Bell, Scott C" sort="Bell, Scott C" uniqKey="Bell S" first="Scott C" last="Bell">Scott C. Bell</name><affiliation><nlm:affiliation>The Prince Charles Hospital, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Brownlee, Keith" sort="Brownlee, Keith" uniqKey="Brownlee K" first="Keith" last="Brownlee">Keith Brownlee</name><affiliation><nlm:affiliation>Cystic Fibrosis Trust, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Burgel, Pierre Regis" sort="Burgel, Pierre Regis" uniqKey="Burgel P" first="Pierre-Régis" last="Burgel">Pierre-Régis Burgel</name><affiliation><nlm:affiliation>Université de Paris, Inserm U1016, Institut Cochin and Cochin Hospital, Assistance Publique Hôpitaux de Paris (APHP).</nlm:affiliation></affiliation></author><author><name sortKey="Byrnes, Cass" sort="Byrnes, Cass" uniqKey="Byrnes C" first="Cass" last="Byrnes">Cass Byrnes</name><affiliation><nlm:affiliation>University of Auckland, Auckland, New Zealand.</nlm:affiliation></affiliation></author><author><name sortKey="Corvol, Harriet" sort="Corvol, Harriet" uniqKey="Corvol H" first="Harriet" last="Corvol">Harriet Corvol</name><affiliation><nlm:affiliation>Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Cheng, Stephanie Y" sort="Cheng, Stephanie Y" uniqKey="Cheng S" first="Stephanie Y" last="Cheng">Stephanie Y. Cheng</name><affiliation><nlm:affiliation>Cystic Fibrosis Canada, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Elbert, Alexander" sort="Elbert, Alexander" uniqKey="Elbert A" first="Alexander" last="Elbert">Alexander Elbert</name><affiliation><nlm:affiliation>Cystic Fibrosis Foundation, Bethesda, US.</nlm:affiliation></affiliation></author><author><name sortKey="Faro, Albert" sort="Faro, Albert" uniqKey="Faro A" first="Albert" last="Faro">Albert Faro</name><affiliation><nlm:affiliation>Cystic Fibrosis Foundation, Bethesda, US.</nlm:affiliation></affiliation></author><author><name sortKey="Goss, Christopher H" sort="Goss, Christopher H" uniqKey="Goss C" first="Christopher H" last="Goss">Christopher H. Goss</name><affiliation><nlm:affiliation>University of Washington, Seattle, US.</nlm:affiliation></affiliation></author><author><name sortKey="Gulmans, Vincent" sort="Gulmans, Vincent" uniqKey="Gulmans V" first="Vincent" last="Gulmans">Vincent Gulmans</name><affiliation><nlm:affiliation>Dutch CF Foundation NCFS, Baarn, Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Marshall, Bruce C" sort="Marshall, Bruce C" uniqKey="Marshall B" first="Bruce C" last="Marshall">Bruce C. Marshall</name><affiliation><nlm:affiliation>Cystic Fibrosis Foundation, Bethesda, US.</nlm:affiliation></affiliation></author><author><name sortKey="Mckone, Edward" sort="Mckone, Edward" uniqKey="Mckone E" first="Edward" last="Mckone">Edward Mckone</name><affiliation><nlm:affiliation>St Vincent's University Hospital, Dublin, Ireland.</nlm:affiliation></affiliation></author><author><name sortKey="Middleton, Peter G" sort="Middleton, Peter G" uniqKey="Middleton P" first="Peter G" last="Middleton">Peter G. Middleton</name><affiliation><nlm:affiliation>Westmead Hospital, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Ruseckaite, Rasa" sort="Ruseckaite, Rasa" uniqKey="Ruseckaite R" first="Rasa" last="Ruseckaite">Rasa Ruseckaite</name><affiliation><nlm:affiliation>Monash University, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Stephenson, Anne L" sort="Stephenson, Anne L" uniqKey="Stephenson A" first="Anne L" last="Stephenson">Anne L. Stephenson</name><affiliation><nlm:affiliation>Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Paris, France; Toronto Adult Cystic Fibrosis Centre, St. Michael's Hospital, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Carr, Siobhan B" sort="Carr, Siobhan B" uniqKey="Carr S" first="Siobhán B" last="Carr">Siobhán B. Carr</name><affiliation><nlm:affiliation>Royal Brompton Hospital and Imperial College London, UK.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society</title><idno type="eISSN">1873-5010</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Australia (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Canada (MeSH)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (therapy)</term><term>Cystic Fibrosis (complications)</term><term>Cystic Fibrosis (therapy)</term><term>Cystic Fibrosis (virology)</term><term>Europe (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>New Zealand (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (therapy)</term><term>Symptom Assessment (MeSH)</term><term>United States (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Australia</term><term>Canada</term><term>Europe</term><term>New Zealand</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Cystic Fibrosis</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Cystic Fibrosis</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Cystic Fibrosis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Betacoronavirus</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Symptom Assessment</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2, on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in people with cystic fibrosis.</div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Anonymised data submitted by each participating country to their National CF Registry was reported using a standardised template, then collated and summarised.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>40 cases have been reported across 8 countries. Of the 40 cases, 31 (78%) were symptomatic for SARS-CoV-2 at presentation, with 24 (60%) having a fever. 70% have recovered, 30% remain unresolved at time of reporting, and no deaths have been submitted.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort. The disease course does not seem to differ from the general population, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32376098</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5010</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>05</Month></PubDate></JournalIssue><Title>Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society</Title><ISOAbbreviation>J. Cyst. Fibros.</ISOAbbreviation></Journal><ArticleTitle>A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.</ArticleTitle><Pagination><MedlinePgn>355-358</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1569-1993(20)30125-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcf.2020.04.012</ELocationID><Abstract><AbstractText>Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2, on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in people with cystic fibrosis.</AbstractText><AbstractText Label="METHODS">Anonymised data submitted by each participating country to their National CF Registry was reported using a standardised template, then collated and summarised.</AbstractText><AbstractText Label="RESULTS">40 cases have been reported across 8 countries. Of the 40 cases, 31 (78%) were symptomatic for SARS-CoV-2 at presentation, with 24 (60%) having a fever. 70% have recovered, 30% remain unresolved at time of reporting, and no deaths have been submitted.</AbstractText><AbstractText Label="CONCLUSIONS">This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort. The disease course does not seem to differ from the general population, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection.</AbstractText><CopyrightInformation>Copyright © 2020. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cosgriff</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cystic Fibrosis Trust, London, UK. Electronic address: rebecca.cosgriff@cysticfibrosis.org.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahern</LastName><ForeName>Susannah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Scott C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>The Prince Charles Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brownlee</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cystic Fibrosis Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgel</LastName><ForeName>Pierre-Régis</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Université de Paris, Inserm U1016, Institut Cochin and Cochin Hospital, Assistance Publique Hôpitaux de Paris (APHP).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrnes</LastName><ForeName>Cass</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corvol</LastName><ForeName>Harriet</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Stephanie Y</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Cystic Fibrosis Canada, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elbert</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cystic Fibrosis Foundation, Bethesda, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faro</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cystic Fibrosis Foundation, Bethesda, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goss</LastName><ForeName>Christopher H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulmans</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Dutch CF Foundation NCFS, Baarn, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Bruce C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Cystic Fibrosis Foundation, Bethesda, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKone</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Middleton</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Westmead Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruseckaite</LastName><ForeName>Rasa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Anne L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Paris, France; Toronto Adult Cystic Fibrosis Centre, St. Michael's Hospital, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>Siobhán B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital and Imperial College London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Cyst Fibros</MedlineTA><NlmUniqueID>101128966</NlmUniqueID><ISSNLinking>1569-1993</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003550" MajorTopicYN="N">Cystic Fibrosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N" Type="Geographic">New Zealand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Coronavirus</Keyword><Keyword MajorTopicYN="Y">Cystic fibrosis</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors have no conflicts of interest to declare relating to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32376098</ArticleId><ArticleId IdType="pii">S1569-1993(20)30125-9</ArticleId><ArticleId IdType="doi">10.1016/j.jcf.2020.04.012</ArticleId><ArticleId IdType="pmc">PMC7183287</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001428 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001428 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32376098
|texte= A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32376098" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |